BioSpace News Archive

Deals

Imara Announces Pricing of Public Offering - July 14, 2021

Imara Inc. announced the pricing of its previously announced underwritten public offering of shares of its common stock at a public offering price of $6.00 per share, for gross proceeds of $50 million, before underwriting discounts and commissions and offering expenses payable by the Company.

July 13, 2021
·
4 min read
FDA

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled “The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma”

July 13, 2021
·
5 min read
FDA

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study, AVM0703-001, entitled “The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma”.

July 13, 2021
·
5 min read
Business

Athersys to Host Second Quarter 2021 Financial Results Call

Athersys, Inc. will release its second quarter 2021 financial results at approximately 4:00 PM Eastern Time on Monday, August 9, 2021, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

July 13, 2021
·
2 min read
Genetown

Oncopeptides’ PEPAXTO ® Receives a Specific C-Code and Pass-Through Payment Status Further Streamlining Reimbursement in Hospital Sites of Care

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that the Centers for Medicare and Medicaid Services (CMS) have established a specific C-Code for PEPAXTO®, C9080.

July 13, 2021
·
2 min read
Bio NC

RedHill Biopharma’s Movantik® Added as Unrestricted Preferred Brand To A Major National Commercial Formulary Serving over 30 Million Americans

Movantik® included as preferred brand with no restrictions on a National Formulary of one of America’s largest payors as of July 1st 2021

July 13, 2021
·
9 min read
Pharm Country

Stryker Introduces Market-Leading Tornier Shoulder Arthroplasty Portfolio and Launches New Tornier Perform™ Humeral System

Stryker, one of the world’s leading medical technology companies, has officially introduced the Tornier shoulder arthroplasty portfolio and launched its first new Tornier product, the Perform™ Humeral Stem.

July 13, 2021
·
3 min read
GT Molecular Launches Highly Sensitive PCR Tests for the SARS-CoV-2 Delta Variant and Influenza A/B

GT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2).

July 13, 2021
·
2 min read
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells

ImCheck Therapeutics today announced the publication of preclinical data elucidating the fundamental role of butyrophilins (BTNs) in the activation of V gamma 9 V delta 2 (Vγ9Vδ2) T cells leading to an anti-tumor immune response in the peer-reviewed journal, Cell Reports

July 13, 2021
·
3 min read
Business

Pandemic Response Lab and Brio Announce Partnership to Provide Innovative Molecular Diagnostics Testing Solutions for the Entertainment Industry

The Pandemic Response Lab (PRL) and Brio today announced they are partnering to provide COVID-19 testing and variant “zone” surveillance tracking to mitigate the risk of new and emerging variants for the entertainment industry.

July 13, 2021
·
4 min read